A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours.

The pilot will involve 20 liver-cancer patients who have exhausted all other avenues of treatment but still have the liver function required to “process” cannabis oil. This type of study has not been carried out before, according to the research team. “It is pioneering in many ways,” said surgeon and lead researcher Maarten Nijkamp.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Two studies seek to show the benefits of cannabinoids for liver health ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Two studies seek to show the benefits of cannabinoids for liver health ”






      A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours.

      The pilot will involve 20 liver-cancer patients who have exhausted all other avenues of treatment but still have the liver function required to “process” cannabis oil. This type of study has not been carried out before, according to the research team. “It is pioneering in many ways,” said surgeon and lead researcher Maarten Nijkamp.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik